Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Markets
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Markets — Monitoring
Wednesday, 23 October
13:20
Improving delivery of healthcare programmes
13:20
to
14:50
Central square 3 (C3)
Graça Vilar
Thursday, 24 October
13:20
Regulating the low-THC cannabis market in Europe
13:20
to
14:50
Futures zone 1 (F1)
Davide Fortin
15:00
Drug markets
15:00
to
16:30
Insights zone 4 (I4)
Dirk Korf
16:50
Emerging drug trends in North Africa and Middle East
Focus on the EU borders
16:50
to
18:20
Insights zone 2 (I2)
Ioanna Yiasemi
Thomas Néfau
Gambling research
16:50
to
18:20
Networking zone 1 (N1)
Luke Clark
Friday, 25 October
09:00
Illicit drug markets: strategic analysis for a safer Europe
09:00
to
10:30
Insights zone 2 (I2)
Roumen Sedefov
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
13:30
Oral presentation
Balancing welfare and market institutional logics. Procurement regulations for social services, such as addiction treatment, in four Nordic welfare countries
13:30
to
13:45
Central square 3 (C3)
Kerstin Stenius
13:45
Oral presentation
Can liaison and diversion services increase referral to drug and alcohol treatment?
13:45
to
14:00
Central square 3 (C3)
Kate Morley
14:00
Oral presentation
Treatment in therapeutic communities: the experience of Lisbon and Tagus Valley Region
14:00
to
14:15
Central square 3 (C3)
Elizabete Pereira
14:15
Oral presentation
The influence of institutional response on the individual's recovery from drug misuse
14:15
to
14:30
Central square 3 (C3)
Carolina Cunha
Thursday, 24 October
13:30
Oral presentation
Low THC cannabis products in the EU
13:30
to
13:45
Futures zone 1 (F1)
Brendan Hughes
13:45
Oral presentation
Low-THC cannabis: results of a survey among Swiss users
13:45
to
14:00
Futures zone 1 (F1)
Frank Zobel
14:00
Oral presentation
Creating the light cannabis market in the EU: the Italian consumer experience
14:00
to
14:15
Futures zone 1 (F1)
Davide Fortin
15:10
Oral presentation
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands
15:10
to
15:25
Insights zone 4 (I4)
Daan van der Gouwe
15:40
Oral presentation
A descriptive analysis of the illicit supply of new psychoactive substances within and from China
15:40
to
15:55
Insights zone 4 (I4)
Minqi Zhao
15:55
Oral presentation
MDMA dosage in XTC tablets: size matters
15:55
to
16:10
Insights zone 4 (I4)
Ruben Vrolijk
16:10
Oral presentation
Understanding drug markets: results of the MARSTUP study
16:10
to
16:25
Insights zone 4 (I4)
Frank Zobel
17:00
Oral presentation
'I shouldn’t have taken that bet!': counterfactual thinking in gambling disorder
17:00
to
17:15
Networking zone 1 (N1)
Luke Clark
Oral presentation
Framing the non-medical use of tramadol in Africa- global opioid crises, medicrime or inadequate healthcare systems
17:00
to
17:20
Insights zone 2 (I2)
Axel Klein
17:15
Oral presentation
Income-related inequality in gambling: evidence from Italy
17:15
to
17:30
Networking zone 1 (N1)
Giuliano Resce
17:20
Oral presentation
Captagon: knowns and unknows
17:20
to
17:35
Insights zone 2 (I2)
Laurent Laniel
17:30
Oral presentation
Socio-ecological model of problem gambling: a cross-national comparison on young people in the United States, South Korea, Spain and Finland
17:30
to
17:45
Networking zone 1 (N1)
Atte Oksanen
17:35
Oral presentation
Libya’s changing drug trafficking dynamics on the coastal and desert borders
17:35
to
17:50
Insights zone 2 (I2)
Mark Micallef
17:45
Oral presentation
Online poker : loss of control and gambling disorder
17:45
to
18:00
Networking zone 1 (N1)
Axelle Moreau
17:50
Oral presentation
Harm reduction services in MENA region: Assessment of the situation and response by MENAHRA
17:50
to
18:05
Insights zone 2 (I2)
Elie Aaraj
18:00
Oral presentation
Marketing stimuli and their perceived effects among sports bettors in treatment for gambling disorder
18:00
to
18:15
Networking zone 1 (N1)
Hibai Lopez-Gonzalez
18:05
Oral presentation
Wastewater-based drug epidemiology data in selected community compared to a forensic toxicology investigation finding. Sewage sensors towards evaluation of drug use trends
18:05
to
18:20
Insights zone 2 (I2)
Bilel Moslah
Friday, 25 October
09:10
Oral presentation
A framework for understanding the EU illicit drug market
09:10
to
09:25
Insights zone 2 (I2)
Nicola Singleton
09:25
Oral presentation
Ramifications of illicit drug markets: pilot data on drug-related homicide
09:25
to
09:40
Insights zone 2 (I2)
Teodora Groshkova
09:55
Oral presentation
The European markets for cannabis, heroin and cocaine
09:55
to
10:10
Insights zone 2 (I2)
Laurent Laniel
10:10
Oral presentation
The European markets for synthetic stimulants and new psychoactive substances
10:10
to
10:25
Insights zone 2 (I2)
Andrew Cunningham